https://regulatorynews.com/edwards-pascal-precision-tricuspid-physicians Regulatory News en 2026-10-27T11:17:16-04:00 FDA Approves Second Device for Tricuspid Repair https://regulatorynews.com/elucid-bioimaging-ffr-iq-fda-clearance Regulatory News en 2026-10-27T10:28:53-04:00 Elucid Wins FDA Clearance for Its FFR-IQ Software https://regulatorynews.com/lucid-diagnostics-esoguard-medicare-reimbursement Regulatory News en 2026-10-27T10:28:53-04:00 Lucid Begins Medicare Payment for EsoGuard DNA Test https://regulatorynews.com/sumitomo-enzomenib-breakthrough-therapy-designation Regulatory News en 2026-10-27T10:28:53-04:00 Sumitomo Earns FDA Breakthrough Tag for Enzomenib https://regulatorynews.com/awiqli-pediatric-type2-diabetes-approval Regulatory News en 2026-10-27T06:02:18-04:00 FDA Approves Weekly Insulin Awiqli for Pediatric T2D https://regulatorynews.com/biomerieux-spotfire-vaginitis-fda-clearance Regulatory News en 2026-10-27T06:02:18-04:00 FDA Clears bioMérieux’s Point-of-Care Vaginitis Panel https://regulatorynews.com/fda-cosmetics-mandatory-recall-guidance Regulatory News en 2026-10-27T06:02:18-04:00 FDA Finalizes Its Mandatory Cosmetics Recall Guidance https://regulatorynews.com/hibsago-bepirovirsen-hepatitis-b-physicians Regulatory News en 2026-10-26T10:58:33-04:00 FDA Approves Hibsago, First Antisense Hepatitis B Drug https://regulatorynews.com/orladeyo-pellets-12-and-older-physicians Regulatory News en 2026-10-26T10:58:33-04:00 FDA Extends Orladeyo Pellets to Teens, Adults With HAE https://regulatorynews.com/city-therapeutics-nasdaq-ipo-rnai-financing Regulatory News en 2026-10-26T10:00:20-04:00 City Therapeutics Closes $230M Nasdaq IPO https://regulatorynews.com/rivanna-boneenhance-fda-clearance Regulatory News en 2026-10-26T10:00:20-04:00 RIVANNA Wins FDA Clearance for BoneEnhance AI https://regulatorynews.com/teleflex-freesolve-rms-coronary-breakthrough-designation Regulatory News en 2026-10-26T10:00:20-04:00 Teleflex's Freesolve Scaffold Wins 2nd Breakthrough Tag https://regulatorynews.com/biocryst-orladeyo-pellets-age-expansion Regulatory News en 2026-10-26T06:08:37-04:00 FDA Extends Orladeyo Pellets to Patients 12 and Up https://regulatorynews.com/fda-olympus-import-alert-gi-expansion Regulatory News en 2026-10-26T06:08:37-04:00 FDA Widens Olympus Import Alert to GI Scopes https://regulatorynews.com/safe-medicines-peptide-compounding-petition Regulatory News en 2026-10-26T06:08:37-04:00 Safety Group Asks FDA to Block Peptide Compounding